Vaxart (VXRT) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free VXRT Stock Alerts $1.02 +0.08 (+8.51%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 5:14 AM | americanbankingnews.comVaxart (NASDAQ:VXRT) Stock Price Passes Above 200-Day Moving Average of $0.89May 14 at 9:03 AM | insidermonkey.comVaxart, Inc. (NASDAQ:VXRT) Q1 2024 Earnings Call TranscriptMay 14 at 6:50 AM | finance.yahoo.comVaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...May 13 at 4:01 PM | globenewswire.comVaxart Provides Business Update and Reports First Quarter 2024 Financial ResultsMay 12, 2024 | markets.businessinsider.comVaxart earnings preview: what to expectMay 11, 2024 | americanbankingnews.comVaxart (VXRT) to Release Quarterly Earnings on MondayMay 8, 2024 | marketbeat.comVaxart (VXRT) Scheduled to Post Earnings on MondayVaxart (NASDAQ:VXRT) will be releasing earnings after the market closes on Monday, May 13, Zacks reports.May 7, 2024 | finance.yahoo.comVaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13April 30, 2024 | globenewswire.comVaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersApril 9, 2024 | investorplace.comElection Year Encore: Can 2020's Top 7 Stock Winners Repeat Their Performance in 2024?March 27, 2024 | globenewswire.comVaxart to Present at World Vaccine Congress Washington 2024 on April 3March 22, 2024 | marketbeat.comVaxart, Inc. (NASDAQ:VXRT) Expected to Earn Q1 2024 Earnings of ($0.18) Per ShareVaxart, Inc. (NASDAQ:VXRT - Free Report) - Equities research analysts at B. Riley issued their Q1 2024 earnings estimates for shares of Vaxart in a research note issued on Wednesday, March 20th. B. Riley analyst M. Mamtani expects that the biotechnology company will earn ($0.18) per share for theMarch 21, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Vaxart, Inc.'s Q2 2024 Earnings (NASDAQ:VXRT)Vaxart, Inc. (NASDAQ:VXRT - Free Report) - Investment analysts at B. Riley issued their Q2 2024 earnings per share estimates for Vaxart in a report issued on Wednesday, March 20th. B. Riley analyst M. Mamtani forecasts that the biotechnology company will earn ($0.15) per share for the quarter. B.March 20, 2024 | globenewswire.comVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 17, 2024 | finance.yahoo.comEstimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)March 15, 2024 | finance.yahoo.comVaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | investorplace.comVXRT Stock Earnings: Vaxart Beats EPS, Beats Revenue for Q4 2023March 14, 2024 | finance.yahoo.comVaxart Inc (VXRT) Reports Full Year 2023 Financial ResultsMarch 14, 2024 | globenewswire.comVaxart Provides Business Update and Reports Full Year 2023 Financial ResultsMarch 8, 2024 | marketbeat.comVaxart (VXRT) Set to Announce Quarterly Earnings on ThursdayVaxart (NASDAQ:VXRT) will be releasing earnings after the market closes on Thursday, March 14, Zacks reports.March 7, 2024 | globenewswire.comVaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14March 6, 2024 | marketwatch.comVaxart Names Steven Lo President, Chief ExecutiveMarch 6, 2024 | globenewswire.comVaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and DirectorFebruary 20, 2024 | finance.yahoo.comVAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?February 5, 2024 | finance.yahoo.comVaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 ChallengeFebruary 2, 2024 | marketbeat.comBrokers Set Expectations for Vaxart, Inc.'s FY2023 Earnings (NASDAQ:VXRT)Vaxart, Inc. (NASDAQ:VXRT - Free Report) - B. Riley boosted their FY2023 earnings per share estimates for Vaxart in a note issued to investors on Wednesday, January 31st. B. Riley analyst M. Mamtani now expects that the biotechnology company will earn ($0.66) per share for the year, up from theirJanuary 31, 2024 | marketbeat.comVaxart (NASDAQ:VXRT) Raised to "Buy" at B. RileyB. Riley upgraded shares of Vaxart from a "neutral" rating to a "buy" rating and set a $2.00 price target for the company in a research report on Wednesday.January 16, 2024 | marketwatch.comVaxart CEO Resigns; Biotech Raises $10 Million in Stock SaleJanuary 16, 2024 | finance.yahoo.comVaxart, Inc. Announces Management ChangeJanuary 16, 2024 | finance.yahoo.comVaxart Announces $10.0 Million Registered Direct Offering with RA Capital ManagementDecember 21, 2023 | finance.yahoo.comVaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNovember 7, 2023 | finance.yahoo.comHere's Why Vaxart (NASDAQ:VXRT) Must Use Its Cash WiselyNovember 3, 2023 | finance.yahoo.comVaxart, Inc. (NASDAQ:VXRT) Q3 2023 Earnings Call TranscriptNovember 3, 2023 | finance.yahoo.comVaxart Inc (VXRT) Reports Q3 2023 Financial Results and Business UpdatesNovember 2, 2023 | finance.yahoo.comVaxart Provides Business Update and Reports Third Quarter 2023 Financial ResultsNovember 2, 2023 | finance.yahoo.comVaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersOctober 26, 2023 | finance.yahoo.comVaxart to Host Third Quarter 2023 Business Update and Financial Results Conference Call on November 2September 21, 2023 | finance.yahoo.comVaxart to Participate in Fireside Chat at 2023 Cantor Global Healthcare ConferenceSeptember 10, 2023 | markets.businessinsider.comVaxart (VXRT) Receives a Buy from Cantor FitzgeraldAugust 22, 2023 | finance.yahoo.comStrong week for Vaxart (NASDAQ:VXRT) shareholders doesn't alleviate pain of three-year lossAugust 15, 2023 | finance.yahoo.comBears are Losing Control Over VAXART, INC. (VXRT), Here's Why It's a 'Buy' NowAugust 6, 2023 | forbes.comConvert South Korean Won To Australian DollarAugust 5, 2023 | forbes.comConvert Australian Dollar To Nigerian NairaAugust 5, 2023 | finance.yahoo.comVaxart, Inc. (NASDAQ:VXRT) Q2 2023 Earnings Call TranscriptAugust 4, 2023 | forbes.comConvert Australian Dollar To Nepalese RupeeAugust 3, 2023 | finance.yahoo.comVaxart Provides Business Update and Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comVAXART, INC. (VXRT) Reports Q2 Loss, Tops Revenue EstimatesAugust 2, 2023 | forbes.comConvert Australian Dollar To Pakistani RupeeAugust 1, 2023 | forbes.comConvert Australian Dollar To Zimbabwean DollarJuly 29, 2023 | forbes.comConvert Australian Dollar To Mongolian Tugrik Get Vaxart News Delivered to You Automatically Sign up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Investment of the Decade… (Ad)Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade. To get all the details of this controversial tech – click here now. VXRT Media Mentions By Week VXRT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VXRT News Sentiment▼0.890.55▲Average Medical News Sentiment VXRT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VXRT Articles This Week▼81▲VXRT Articles Average Week Get Vaxart News Delivered to You Automatically Sign up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DBV Technologies News Today Molecular Partners News Today Cardiol Therapeutics News Today Vigil Neuroscience News Today Omega Therapeutics News Today Scilex News Today aTyr Pharma News Today Cardiff Oncology News Today BioAtla News Today Sangamo Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VXRT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & CompanyWhy Is Gold On a MASSIVE rally? Huge AlertsProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxart, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
